Inventor
XIONG JING
CN23 patents
⚠️ This page may combine multiple inventors who share the name “XIONG JING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
5 patentsUS11873302B2Jan 16, 2024
Solid forms of a compound of HBV core protein allosteric modifier
HOFFMANN LA ROCHE2 citations72
US11230559B2Jan 25, 2022
Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate
HOFFMANN LA ROCHE4 citations71
US12012420B2Jun 18, 2024
Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
HOFFMANN LA ROCHE0 citations60
US12012421B2Jun 18, 2024
Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
HOFFMANN LA ROCHE0 citations60
US11142534B2Oct 12, 2021
Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
HOFFMANN LA ROCHE0 citations48
BUSCHMANN NICOLE
4 patentsUS9266883B2Feb 23, 2016
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE16 citations90
US9533988B2Jan 3, 2017
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE13 citations82
US9896449B2Feb 20, 2018
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
BUSCHMANN NICOLE2 citations71
US9802917B2Oct 31, 2017
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
BUSCHMANN NICOLE2 citations70
FORCOME ZHEJIANG CO LTD
3 patentsNOVARTIS AG
3 patentsUS10130629B2Nov 20, 2018
Pharmaceutical combinations
NOVARTIS AG3 citations71
US10463653B2Nov 5, 2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations51
US10507201B2Dec 17, 2019
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
NOVARTIS AG0 citations49